Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keiichiro Yogo is active.

Publication


Featured researches published by Keiichiro Yogo.


FEBS Letters | 2002

Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells

Keiichiro Yogo; Takuya Ogawa; Motofusa Akiyama; Norihiro Ishida; Tatsuo Takeya

The gap junctional intercellular communication mediated by Cx43 plays indispensable roles in both germ line development and postnatal folliculogenesis. In this study, we focused on the effect of follicle‐stimulating hormone (FSH) on the Cx43 protein in rat primary granulosa cells and found that FSH stimulation elevated the phosphorylation in addition to the protein level of Cx43. Serine residues in the carboxyl‐terminal region were exclusively phosphorylated in this system and we identified Ser365, Ser368, Ser369 and Ser373 as major phosphorylation sites by FSH stimulation. A Cx43 variant containing mutations at all these serine residues was found to severely reduce dye transfer activity when assayed in HeLa cells. The present study revealed a novel regulatory mechanism of Cx43‐mediated gap junctional intercellular communication through phosphorylation in the carboxyl‐terminus.


Organic and Biomolecular Chemistry | 2008

Solubilisation of [60]fullerenes using block copolymers and evaluation of their photodynamic activities

Motofusa Akiyama; Atsushi Ikeda; Takashi Shintani; Yuki Doi; Jun-ichi Kikuchi; Takuya Ogawa; Keiichiro Yogo; Tatsuo Takeya; Naoyuki Yamamoto

Unmodified [60]fullerenes (C60) were solubilised with high stability using various type of poly(ethylene glycol) (PEG) based block copolymer micelles. Block copolymer micelle-incorporated C60 fullerenes were studied in cultures for biological activities using human cervical cancer HeLa cells. As a result, the cationic block copolymer micelles delivered C60 into the cells depending on their surface densities and showed cytotoxicity under photoirradiation.


Journal of Bone and Mineral Research | 2005

CCR1 Acts Downstream of NFAT2 in Osteoclastogenesis and Enhances Cell Migration

Norihiro Ishida; Koji Hayashi; Asuka Hattori; Keiichiro Yogo; Toru Kimura; Tatsuo Takeya

We found that a chemokine receptor gene, CCR1, acts downstream of NFAT2 in RANKL‐stimulated RAW264 and bone marrow cells. The upstream regulatory region of CCR1 showed RANKL‐dependent and CsA‐suppressible promoter activity. Downregulation of the expression and function of CCR1 suppressed cell migration.


Journal of Dairy Science | 2011

Purification and identification of lactoperoxidase in milk basic proteins as an inhibitor of osteoclastogenesis

Yoshikazu Morita; A. Ono; A. Serizawa; Keiichiro Yogo; Norihiro Ishida-Kitagawa; Tatsuo Takeya; Takuya Ogawa

A milk protein fraction with alkaline isoelectric points (milk basic protein, MBP) inhibits both bone resorption and osteoclastogenesis for in vitro models. We previously identified bovine angiogenin as a component of MBP that inhibits bone resorption. However, purified angiogenin had no effect on osteoclastogenesis, suggesting that MBP contains unidentified component(s) that inhibit osteoclast formation. In this study, we purified lactoperoxidase (LPO) as the predominant inhibitor of osteoclastogenesis in MBP. The LPO treatment downregulated levels of reactive oxygen species in osteoclasts. Signaling by receptor activator of NF-kappa-B ligand/receptor activator of NF-kappa-B (RANKL/RANK) was downregulated in LPO-treated cells, and, in particular, the ubiquitination of tumor necrosis factor receptor associate factor 6 (TRAF6) and activation of downstream signaling cascades (JNK, p38, ERK, and NFκB) were suppressed. Ultimately, LPO treatment led to decreased expression of c-Fos and NFAT2. These results suggest that MBP contains at least 2 components that independently suppress bone resorption through a unique mechanism: angiogenin inhibits bone resorption and LPO inhibits RANKL-induced osteoclast differentiation. These data explain many of the positive aspects of milk consumption on bone health.


Journal of Endocrinology | 2010

Evidence for expression of relaxin hormone-receptor system in the boar testis

Shinichi Kato; Siqin; Itaru Minagawa; Takuya Aoshima; Dai Sagata; Hirokazu Konishi; Keiichiro Yogo; Tatsuo Kawarasaki; Hiroshi Sasada; Hiroshi Tomogane; Tetsuya Kohsaka

Although the physiological role of relaxin (RLN) in males remains largely unknown, there is limited evidence that the testis might be a candidate source and target of RLN in boars, as RLN transcripts are detected in the boar testis and it contains RLN-binding sites. To determine whether the boar testis acts as a source and target tissue of RLN, we characterised the expression pattern and cellular localisation of both RLN and its own receptor LGR7 (RXFP1) in boar testes during postnatal development by molecular and immunological approaches. Testes were collected from Duroc boars, and partial cDNA sequences of the boar homologue of human RXFP1 were identified. RLN expression increased through puberty onwards, while RXFP1 expression changed little during development. RLN mRNA and protein expression were restricted to the Leydig cells, whereas both Leydig cells and seminiferous epithelial cells expressed RXFP1 mRNA and protein. Interestingly, RLN was expressed in the testis as an 18 kDa form (the expected size of proRLN), but not as the 6 kDa mature form, during development because of a lack of the enzyme required for proRLN processing. In contrast, RXFP1 was detected at all stages as specific bands of 75 and 91-95 kDa (likely non-glycosylated and glycosylated RXFP1 respectively). Thus, we provide evidence for expression of RLN-RXFP1 ligand-receptor system in the boar testis, suggesting that the testis act as a source and possible target tissue of RLN.


Molecular and Cellular Endocrinology | 2003

Synergistic effects of activin and FSH on hyperphosphorylation of Rb and G1/S transition in rat primary granulosa cells.

Takuya Ogawa; Keiichiro Yogo; Norihiro Ishida; Tatsuo Takeya

Activin is produced in mammalian ovarian follicles and is known to function as a paracrine as well as autocrine factor for folliculogenesis and oogenesis. We investigated the functional mechanism of activin using a hormone-supplemented serum-free culture system of granulosa cells isolated from diethylstilbestrol (DES)-primed 21-day-old rats. Recombinant human-activin A appeared to induce CycD2 and to act synergistically with FSH to promote G1/S transition and cell proliferation starting from 12h after stimulation, accompanied by an increase of the hyperphosphorylated retinoblastoma protein (ppRb). Cells from unprimed rats gave similar results. FSH, in contrast, showed no CycD2-inducing activity, but turned out to modulate CycD2/cdk4 complex formation and enhance ppRb formation in conjunction with activin. These findings showed that the induction of CycD2 by activin and the synergistic effect of activin with FSH on ppRb formation play important roles in promoting G1/S transition in rat primary granulosa cells.


Journal of Animal Science | 2010

Identification and expression analysis of connexin-45 and connexin-60 as major connexins in porcine oocytes.

Mai Nitta; Keiichiro Yogo; M. Ohashi; Motofusa Akiyama; Y. Kunitomo; Takuya Ogawa; Norihiro Ishida-Kitagawa; Jun Miyoshi; E. Sato; Tatsuo Takeya

During mammalian oogenesis, intercellular communication between oocytes and the surrounding follicle cells through gap junction channels is crucial for oocyte development and maturation. The channel properties of gap junctions may be affected by the composition or combination of connexins, the expression of which is regulated by gonadotropins and other factors. Thus, identification and expression analysis of connexin genes in oocytes and follicle cells will help us to better understand how oogenesis and folliculogenesis are regulated in a species-specific manner in mammals. We previously reported the spatiotemporal expression of multiple connexin genes in porcine follicle cells. Here, we searched for connexin genes specifically expressed in porcine oocytes that may be involved in the formation of gap junctions between oocytes and follicle cells. To achieve this, we constructed an oocyte-specific cDNA library to identify which connexin genes are expressed in these cells and found that gap junction protein, alpha 10, which encodes connexin-60, and a porcine ortholog of mouse gap junction protein, gamma 1 encoding connexin-45, are the major connexins expressed in porcine oocytes during folliculogenesis. Immunostaining and in situ hybridization of sectioned porcine ovaries confirmed oocyte expression of these genes at 3 different stages of ovary development. Furthermore, their gap junction channel activity was assessed using a heterologous cell system. However, gap junction protein, alpha 4, which encodes connexin-37 and is expressed in the oocytes of several other mammals, was undetectable. We demonstrate that there is diversity in the connexin genes expressed in mammalian oocytes, and hence in the gap junctions connecting oocytes and cumulus cells.


Journal of Bone and Mineral Metabolism | 2006

A novel role of l-serine (l-Ser) for the expression of nuclear factor of activated T cells (NFAT)2 in receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclastogenesis in vitro

Takuya Ogawa; Norihiro Ishida-Kitagawa; Akira Tanaka; Takahiro Matsumoto; Tamayo Hirouchi; Mai Akimaru; Masao Tanihara; Keiichiro Yogo; Tatsuo Takeya

Multinucleated cell formation is crucial for osteoclastogenesis, and the expression of nuclear factor of activated T cells (NFAT)2 (NFATc1) is essential for this process. We previously found, using mouse RAW264 cells, that culture at high cell density blocked progression to the multinucleated cell stage induced by stimulation with receptor activator of nuclear factor κB ligand (RANKL). Here, we have confirmed this finding in a bone marrow cell system and extended the analysis further. A high cell density appeared to cause a change in the composition of the culture medium accompanying downregulation of NFAT2 expression, and we identified l-serine (l-Ser) as essential for the expression of NFAT2 induced by RANKL. Namely, culture at high cell density caused a depletion of l-Ser in the medium. Consequently, l-Ser appeared to exert its effect at an early stage under the regular conditions used for inducing the expression of c-Fos, an upstream regulator of NFAT2. d-Ser, an enantiomer of l-Ser, showed no NFAT2-inducing activity. The expression of NFAT2, using a retrovirus vector, could compensate for the depletion of l-Ser and resume the progression to the multinucleated cell stage. These results demonstrate a novel role for l-Ser in RANKL-induced osteoclastogenesis in vitro.


Annals of the New York Academy of Sciences | 2009

Identification of boar testis as a source and target tissue of relaxin.

Tetsuya Kohsaka; Shinichi Kato; Si Qin; Itaru Minagawa; Keiichiro Yogo; Tatsuo Kawarasaki; Hiroshi Sasada

The expression and cellular localization of relaxin and its own receptor, LGR7/RXFP1, were demonstrated in the boar testis, where relaxin was produced by the Leydig cells as 18‐kDa pro‐relaxin and LGR7/RXFP1 was detected in both Leydig cells and seminiferous epithelial cells, suggesting that a functional relaxin–LGR7/RXFP1 hormone–receptor network operates within the boar testis.


Journal of Biological Chemistry | 2009

Identification of a novel l-serine analog that suppresses osteoclastogenesis in vitro and bone turnover in vivo

Anton Bahtiar; Takahiro Matsumoto; Takashi Nakamura; Motofusa Akiyama; Keiichiro Yogo; Norihiro Ishida-Kitagawa; Takuya Ogawa; Tatsuo Takeya

Osteoclasts are multinucleated giant cells with bone resorbing activity. We previously reported that the expression of the transcription factor NFAT2 (NFATc1) induced by receptor activator of NF-κB ligand (RANKL) is essential for the formation of multinucleated cells. We subsequently identified l-Ser in the differentiation medium as necessary for the expression of NFAT2. Here we searched for serine analogs that antagonize the function of l-Ser and suppress the formation of osteoclasts in bone marrow as well as RAW264 cells. An analog thus identified, H-Ser(tBu)-OMe·HCl, appeared to suppress the production of 3-ketodihydrosphingosine by serine palmitoyltransferase, and the expression and localization of RANK, a cognate receptor of RANKL, in membrane lipid rafts was down-regulated in the analog-treated cells. The addition of lactosylceramide, however, rescued the osteoclastic formation. When administered in vivo, the analog significantly increased bone density in mice and prevented high bone turnover induced by treatment with soluble RANKL. These results demonstrate a close connection between the metabolism of l-Ser and bone remodeling and also the potential of the analog as a novel therapeutic tool for bone destruction.

Collaboration


Dive into the Keiichiro Yogo's collaboration.

Top Co-Authors

Avatar

Tatsuo Takeya

Nara Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Takuya Ogawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Norihiro Ishida-Kitagawa

Nara Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Motofusa Akiyama

Nara Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Norihiro Ishida

Nara Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Atsushi Ikeda

Nara Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Jun-ichi Kikuchi

Nara Institute of Science and Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge